437 related articles for article (PubMed ID: 16309238)
21. Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol.
Li Y; Bhuiyan M; Alhasan S; Senderowicz AM; Sarkar FH
Clin Cancer Res; 2000 Jan; 6(1):223-9. PubMed ID: 10656453
[TBL] [Abstract][Full Text] [Related]
22. Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cells.
Palacios C; Yerbes R; López-Rivas A
Cancer Res; 2006 Sep; 66(17):8858-69. PubMed ID: 16951203
[TBL] [Abstract][Full Text] [Related]
23. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
[TBL] [Abstract][Full Text] [Related]
24. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells.
Motwani M; Delohery TM; Schwartz GK
Clin Cancer Res; 1999 Jul; 5(7):1876-83. PubMed ID: 10430095
[TBL] [Abstract][Full Text] [Related]
25. Identification of effective retinoids for inhibiting growth and inducing apoptosis in bladder cancer cells.
Zou C; Liebert M; Zou C; Grossman HB; Lotan R
J Urol; 2001 Mar; 165(3):986-92. PubMed ID: 11176527
[TBL] [Abstract][Full Text] [Related]
26. Flavopiridol increases therapeutic ratio of radiotherapy by preferentially enhancing tumor radioresponse.
Mason KA; Hunter NR; Raju U; Ariga H; Husain A; Valdecanas D; Neal R; Ang KK; Milas L
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1181-9. PubMed ID: 15234054
[TBL] [Abstract][Full Text] [Related]
27. Carboxyamido-triazole (CAI) reverses the balance between proliferation and apoptosis in a rat bladder cancer model.
Perabo FG; Demant AW; Wirger A; Schmidt DH; Sitia M; Wardelmann E; Müller SC; Kohn EC
Anticancer Res; 2005; 25(2A):725-9. PubMed ID: 15868902
[TBL] [Abstract][Full Text] [Related]
28. Sensitization of tumor cells to ribotoxic stress-induced apoptotic cell death: a new therapeutic strategy.
Rüller S; Stahl C; Köhler G; Eickhoff B; Breder J; Schlaak M; van der Bosch J
Clin Cancer Res; 1999 Oct; 5(10):2714-25. PubMed ID: 10537334
[TBL] [Abstract][Full Text] [Related]
29. The cyclin-dependent kinase (CDK) inhibitor flavopiridol inhibits glycogen phosphorylase.
Kaiser A; Nishi K; Gorin FA; Walsh DA; Bradbury EM; Schnier JB
Arch Biochem Biophys; 2001 Feb; 386(2):179-87. PubMed ID: 11368340
[TBL] [Abstract][Full Text] [Related]
30. Dysoxylum binectariferum Hook.f (Meliaceae), a rich source of rohitukine.
Mohanakumara P; Sreejayan N; Priti V; Ramesha BT; Ravikanth G; Ganeshaiah KN; Vasudeva R; Mohan J; Santhoshkumar TR; Mishra PD; Ram V; Shaanker RU
Fitoterapia; 2010 Mar; 81(2):145-8. PubMed ID: 19686817
[TBL] [Abstract][Full Text] [Related]
31. Flavopiridol binds to duplex DNA.
Bible KC; Bible RH; Kottke TJ; Svingen PA; Xu K; Pang YP; Hajdu E; Kaufmann SH
Cancer Res; 2000 May; 60(9):2419-28. PubMed ID: 10811119
[TBL] [Abstract][Full Text] [Related]
32. Induction of apoptosis and down regulation of cell cycle proteins in mantle cell lymphoma by flavopiridol treatment.
Venkataraman G; Maududi T; Ozpuyan F; Bahar HI; Izban KF; Qin JZ; Alkan S
Leuk Res; 2006 Nov; 30(11):1377-84. PubMed ID: 16624404
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
Schwock J; Pham NA; Cao MP; Hedley DW
Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
[TBL] [Abstract][Full Text] [Related]
34. [Synergism of antitumor effects on ovarian carcinoma using autocatalytic caspase-3 combined with flavopiridol].
Song Y; Shen K; Xu F
Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):781-6. PubMed ID: 21176562
[TBL] [Abstract][Full Text] [Related]
35. In vitro evaluation of flavopiridol, a novel cell cycle inhibitor, in bladder cancer.
Chien M; Astumian M; Liebowitz D; Rinker-Schaeffer C; Stadler WM
Cancer Chemother Pharmacol; 1999; 44(1):81-7. PubMed ID: 10367753
[TBL] [Abstract][Full Text] [Related]
36. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
Bible KC; Kaufmann SH
Cancer Res; 1997 Aug; 57(16):3375-80. PubMed ID: 9269999
[TBL] [Abstract][Full Text] [Related]
37. Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.
Budak-Alpdogan T; Chen B; Warrier A; Medina DJ; Moore D; Bertino JR
Clin Cancer Res; 2009 Feb; 15(4):1232-40. PubMed ID: 19174488
[TBL] [Abstract][Full Text] [Related]
38. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines.
Urech K; Buessing A; Thalmann G; Schaefermeyer H; Heusser P
Anticancer Res; 2006; 26(4B):3049-55. PubMed ID: 16886633
[TBL] [Abstract][Full Text] [Related]
39. Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells.
Raju U; Nakata E; Mason KA; Ang KK; Milas L
Cancer Res; 2003 Jun; 63(12):3263-7. PubMed ID: 12810657
[TBL] [Abstract][Full Text] [Related]
40. Human urinary bladder cancer T24 cells are susceptible to the Antrodia camphorata extracts.
Peng CC; Chen KC; Peng RY; Su CH; Hsieh-Li HM
Cancer Lett; 2006 Nov; 243(1):109-19. PubMed ID: 16455193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
